CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Phase II Study of Oxaliplatin, 5-fluorouracil, and Leucovorin in Relapsed or Metastatic Colorectal Cancer as Second Line Therapy

Duk-Joo Lee, Ho-Suk Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Myung-Ju Ahn

Cancer Research and Treatment. 2006;38(4):201-205. Published online 2006 December 31 DOI: https://doi.org/10.4143/crt.2006.38.4.201

Phase II Study of Oxaliplatin, 5-fluorouracil, and Leucovorin in Relapsed or Metastatic Colorectal Cancer as Second Line Therapy

Duk-Joo Lee, Ho-Suk Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Myung-Ju Ahn

Cancer Research and Treatment. 2006;38(4):201

Link1

Link2

A randomized Phase II clinical study of combining panitumumab and bevacizumab, plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for patients with metastatic colorectal cancer and KRAS mutation

Lijuan Luan, Yuguo Liu, Lijuan Luan

OncoTargets and Therapy. 2015;1061

Link1

Phase II Study of Irinotecan, 5-Fluorouracil, and Leucovorin in Relapsed or Metastatic Colorectal Cancer as First-line Therapy

Young-Woong Won, Young-Hyo Lim, Ho-Yong Park, Ho-Suk Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Myung-Ju Ahn

Cancer Research and Treatment. 2004;36(4):235

Link1

Link2

Phase II Trial of 5-Fluorouracil/Leucovorin/Gemcitabine/Cisplatin as Second-Line Treatment in Patients with Metastatic or Recurrent Colorectal Carcinoma: A Cancer Therapeutics Research Group Study

Alex Y. Chang, Gilberto Lopes, Koo Wen Hsin, Robert Lim, Foo Kian Fong, John Wong

Clinical Colorectal Cancer. 2007;6(9):646-651

Link1 Link2

A Phase II Study of Oxaliplatin, 5-Fluorouracil, Leucovorin, and High-Dose Capecitabine in Patients With Metastatic Colorectal Cancer

Sam J. Lubner, Noelle K. LoConte, Kyle D. Holen, William Schelman, James P. Thomas, Alcee Jumonville, Jens C. Eickhoff, Songwon Seo, Daniel L. Mulkerin

Clinical Colorectal Cancer. 2010;9(3):157-161

Link1 Link2

Phase II Trial of Oxaliplatin/Irinotecan/5-Fluorouracil/Leucovorin for Metastatic Colorectal Cancer

Robert R. McWilliams, Matthew P. Goetz, Bruce W. Morlan, Muhammad Salim, Kendrith M. Rowland, James E. Krook, Matthew M. Ames, Charles Erlichman

Clinical Colorectal Cancer. 2007;6(7):516-521

Link1 Link2

740 POSTER Fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP) as a first line therapy in patients with advanced gastric cancer —interim analysis of a multicenter, randomized phase II trial

European Journal of Cancer Supplements. 2005;3(2):211-212

Link1 Link2

5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study

J. Randolph Hecht, Edith Mitchell, Takayuki Yoshino, Manfred Welslau, Xun Lin, Edna Chow Maneval, Jolanda Paolini, Maria Jose Lechuga, Albrecht Kretzschmar

Cancer Management and Research. 2015;165

Link1

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

Christos Emmanouilides, Georgia Sfakiotaki, Nikolaos Androulakis, Kostas Kalbakis, Charalambos Christophylakis, Antonia Kalykaki, Lambros Vamvakas, Athanasios Kotsakis, Sofia Agelaki, Eleni Diamandidou, Nikolaos Touroutoglou, Adam Chatzidakis, Vassilis Georgoulias, Dimitris Mavroudis, John Souglakos

BMC Cancer. 2007;7(1):

Link1

Link2 Link3 Link4

A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer

Ranhua Cao, Shuai Zhang, Dedong Ma, Likuan Hu

Medical Oncology. 2014;32(1):

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.